Prescription drug · ANDA
Tolterodine Tartrate NDC 16571-127
Tolterodine tartrate 2 mg/1 · Tablet, Film coated · Oral · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 16571-127-01 | 1657101270116571012701 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-127-01)Marketed from Jan 24, 2020 | |
| 16571-127-06 | 1657101270616571012706 | 60 TABLET, FILM COATED in 1 BOTTLE (16571-127-06)Marketed from Jan 24, 2020 | |
| 16571-127-50 | 1657101275016571012750 | 500 TABLET, FILM COATED in 1 BOTTLE (16571-127-50)Marketed from Jan 24, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tolterodine Tartrate
- Generic name (nonproprietary)
- tolterodine tartrate
- Active ingredients
- Tolterodine tartrate — 2 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 16571
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204721
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Muscarinic Antagonists (Mechanism)
- Identifiers
- Product ID 16571-127_d56e7ced-4633-4325-8e3d-166c84c05886SPL ID d56e7ced-4633-4325-8e3d-166c84c05886SPL set ID b9ba8ad2-27f6-4f18-bd84-73659047910eRxCUI 855178, 855194UNII 5T619TQR3RUPC 0316571126064, 0316571127061
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N416571012701followed by a unit qualifier and the quantityPackage 16571-0127-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Excerpt only. Read the full label for complete information.
About NDC 16571-127
- What is NDC 16571-127?
- 16571-127 is the product NDC for Tolterodine Tartrate, Tolterodine tartrate 2 mg/1 tablet, film coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tolterodine Tartrate.
- What is the active ingredient?
- Tolterodine tartrate.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tolterodine Tartrate?
- 31 other product NDCs are listed under this name. See all Tolterodine Tartrate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tolterodine Tartrate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tolterodine Tartrate | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Major Pharmaceuticals | 0904-7574 | 00904-7574-04 |
| Tolterodine Tartrate | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Major Pharmaceuticals | 0904-7575 | 00904-7575-04 |
| Tolterodine tartrate | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Unichem Pharmaceuticals (USA), Inc. | 29300-307 | 29300-0307-0529300-0307-1329300-0307-19 |
| Tolterodine tartrate | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Unichem Pharmaceuticals (USA), Inc. | 29300-306 | 29300-0306-0529300-0306-1329300-0306-19 |
| Tolterodine Tartrate | Tolterodine tartrate 2 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-806 | 31722-0806-0131722-0806-0231722-0806-05+1 more |
| Tolterodine Tartrate | Tolterodine tartrate 1 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-805 | 31722-0805-0131722-0805-0231722-0805-05+1 more |
| Tolterodine Tartrate | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-160 | 70436-0160-0270436-0160-0470436-0160-06 |
| Tolterodine Tartrate | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-161 | 70436-0161-0270436-0161-0470436-0161-06 |
| Tolterodine tartrate | Tolterodine tartrate 2 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-098 | 33342-0098-0933342-0098-1233342-0098-15 |
| Tolterodine tartrate | Tolterodine tartrate 1 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-097 | 33342-0097-0933342-0097-1233342-0097-15 |
Other NDCs under ANDA 204721
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tolterodine Tartrate | Tolterodine tartrate 1 mg/1 | Tablet, Film coatedOral | Rising Pharma Holdings, Inc. | 16571-126 |